Physician profile
Mark H Kumar
NPI 1114929395
$36,865.96
in general payments reported to CMS, 2019-2025
38 companies · $1,749 in 2025
The $1,749 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,985 · 2020: $2,326 · 2021: $5,909 · 2022: $10K · 2023: $7,335 · 2024: $2,222 · 2025: $1,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,159 · Travel and Lodging: $4,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,158.87 |
| Travel and Lodging | $4,147.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,680.61 | 2021-2025 | Valiant Captivia, Endurant Iis, Heli-Fx Endoanchor System |
| Penumbra, INC. | $6,406.65 | 2019-2024 | Indigo System |
| Silk Road Medical, INC. | $3,804.42 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic Vascular, INC. | $2,776.05 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $1,430.62 | 2022-2024 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Bard Peripheral Vascular, INC. | $544.04 | 2020-2025 | Lutonix Drug Coated Balloon, Covera |
| Boston Scientific Corporation | $515.52 | 2020-2025 | Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $455.38 | 2019-2025 | Esprit |
| Cook Medical LLC | $372.16 | 2019-2025 | Zenith Alpha, Zenith |
| Endologix LLC | $330.71 | 2019-2022 | |
| Inari Medical, INC. | $270.06 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $269.10 | 2019-2024 | Xarelto |
| Bolton Medical INC | $211.37 | 2021-2024 | Treo Abdominal Stent-Graft System |
| Imperative Care, INC | $202.32 | 2024 | Symphony Catheter |
| Novo Nordisk INC | $200.08 | 2025 | Wegovy, Ozempic |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $152.20 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $146.21 | 2019 | |
| Smith+Nephew, INC. | $136.08 | 2019 | |
| Lemaitre Vascular, INC. | $123.67 | 2019-2023 | Cardiocel |
| Tactile Systems Technology INC | $112.68 | 2020-2022 | |
| Ekos Corporation | $106.74 | 2019 | |
| Asahi Intecc USA, INC. | $106.65 | 2024-2025 | Asahi Peripheral Vascular Wires, Peripheral Vascular |
| Kci USA, INC. | $83.55 | 2019 | |
| Shape Memory Medical INC. | $72.71 | 2025 | Impede Embolization Plug |
| Chiesi USA, INC. | $47.43 | 2025 | Kengreal |
| Humacyte Global, INC. | $38.36 | 2025 | Symvess |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.18 | 2024-2025 | Lifevest |
| Stryker Corporation | $37.69 | 2021 | |
| Terumo Medical Corporation | $35.34 | 2022 | |
| Artivion, INC. | $30.15 | 2024 | Vascular |
| Astrazeneca Pharmaceuticals Lp | $28.08 | 2021 | |
| Surmodics, INC. | $24.05 | 2023 | Pounce Thrombectomy, Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Angiodynamics, INC. | $22.10 | 2023 | Auryon Laser System 100-120 Vac |
| Medtronic USA, INC. | $20.79 | 2019 | |
| Cvrx, INC. | $18.32 | 2024 | Barostim Neo System |
| Pfizer INC. | $14.04 | 2020 | |
| Reflow Medical INC | $1.85 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.